NYSEAMERICAN:NAVB - Navidea Biopharmaceuticals Price Target & Analyst Ratings

$0.51

-0.02 (-3.77 %)

(As of 08/16/2019 04:00 PM ET)

Add

Compare

Today's Range

$0.50

Now: $0.51▼

$0.53

50-Day Range N/A

52-Week Range

$0.49

Now: $0.51▼

$7.40

Volume20,200 shs

Average Volume186,747 shs

Market Capitalization$5.13 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for Navidea Biopharmaceuticals in the last 12 months. Their average twelve-month price target is $2.00, suggesting that the stock has a possible upside of 292.16%. The high price target for NAVB is $2.00 and the low price target for NAVB is $2.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	N/A	N/A
Consensus Rating Score:	3.00	3.00	N/A	N/A
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$2.00	$2.00	N/A	N/A
Price Target Upside:	292.16% upside	177.78% upside	N/A	N/A